These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2873324)

  • 21. Trends in surgery for screen-detected and interval breast cancers in a national screening programme.
    Nederend J; Duijm LE; Louwman MW; Roumen RM; Jansen FH; Voogd AC
    Br J Surg; 2014 Jul; 101(8):949-58. PubMed ID: 24828281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic surveillance of breast cancer patients: should the mastectomy site be imaged?
    Fajardo LL; Roberts CC; Hunt KR
    AJR Am J Roentgenol; 1993 Nov; 161(5):953-5. PubMed ID: 8273633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
    Conrad B; Kieser R
    Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interval carcinomas of the breast: a group with intermediate outcome.
    Schroën AA; Wobbes T; van der Sluis RF
    J Surg Oncol; 1996 Nov; 63(3):141-4. PubMed ID: 8944056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
    Defossez G; Quillet A; Ingrand P
    BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions.
    Lee JM; Georgian-Smith D; Gazelle GS; Halpern EF; Rafferty EA; Moore RH; Yeh ED; D'Alessandro HA; Hitt RA; Kopans DB
    Radiology; 2008 Aug; 248(2):398-405. PubMed ID: 18539887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up.
    Quiet CA; Ferguson DJ; Weichselbaum RR; Hellman S
    J Clin Oncol; 1995 May; 13(5):1144-51. PubMed ID: 7738620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manchester regional breast study. Preliminary results.
    Lythgoe JP
    Lancet; 1978 Apr; 1(8067):744-7. PubMed ID: 76750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ.
    Wilkinson JB; Vicini FA; Shah C; Shaitelman S; Jawad MS; Ye H; Kestin LL; Goldstein NS; Martinez AA; Benitez P; Chen PY
    Ann Surg Oncol; 2012 Nov; 19(12):3785-91. PubMed ID: 22644510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of interval to definitive breast surgery on clinical presentation and survival in early-stage invasive breast cancer.
    Vujovic O; Yu E; Cherian A; Perera F; Dar AR; Stitt L; Hammond A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):771-4. PubMed ID: 19304404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of early breast cancer.
    Turnbull AR; Turner DT; Chant AD; Shepherd JM; Buchanan RB; Fraser JD
    Lancet; 1978 Jul; 2(8079):7-9. PubMed ID: 78260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group.
    Forrest AP; Stewart HJ; Everington D; Prescott RJ; McArdle CS; Harnett AN; Smith DC; George WD
    Lancet; 1996 Sep; 348(9029):708-13. PubMed ID: 8806289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up.
    Kerlikowske K; Smith-Bindman R; Abraham LA; Lehman CD; Yankaskas BC; Ballard-Barbash R; Barlow WE; Voeks JH; Geller BM; Carney PA; Sickles EA
    Radiology; 2005 Mar; 234(3):684-92. PubMed ID: 15734926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammographic appearance of recurrent breast cancer after breast conservation therapy.
    Weinstein SP; Orel SG; Pinnamaneni N; Tchou J; Czerniecki B; Boraas M; Rosato E; Solin LJ
    Acad Radiol; 2008 Feb; 15(2):240-4. PubMed ID: 18206623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ.
    Liberman L; Van Zee KJ; Dershaw DD; Morris EA; Abramson AF; Samli B
    AJR Am J Roentgenol; 1997 Feb; 168(2):489-93. PubMed ID: 9016233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.
    Webb ML; Cady B; Michaelson JS; Bush DM; Calvillo KZ; Kopans DB; Smith BL
    Cancer; 2014 Sep; 120(18):2839-46. PubMed ID: 24018987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening.
    Demicheli R; Bonadonna G; Hrushesky WJ; Retsky MW; Valagussa P
    J Clin Oncol; 2004 Jan; 22(1):102-7. PubMed ID: 14701771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.